B

내츄럴엔도텍

168330KOSDAQ

56.3 / 100

Reference Date: 2026-09-08

Financial Score15.0 / 40
News Sentiment21.3 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 16.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Naturalendo Tech develops health supplements and cosmeceuticals using natural resources and biotechnology, focusing on anti-aging and health promotion. Through its subsidiary Endoderma, the company researches and produces micro-needle patches based on transdermal drug delivery systems (TDDS). Key products include 'Snut Wonder' for menopausal women and the 'NEEDLY' skincare line, with future goals including global market expansion and enhanced ESG practices.

Number of Employees

83people

Average Salary

49.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 15.004.0Point
PBR
2.98Industry Average 1.200.0Point

2.5x industry avg (risky)

ROE
-14.45Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
30.13Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20254.5 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲9.2% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲10.1% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -15.1% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position3.0Point

52w lower range (25%)

Current 2,180Won52-week high 3,51052-week low 1,727
1-month return6.0Point

1m +16.89% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral[기재정정]반기보고서 (2026.06)2026-08-18
  • Neutral반기보고서 (2026.06)2026-08-14